Literature DB >> 21889812

Dimethylarginines in patients with type 2 diabetes mellitus: relation with the glycaemic control.

Ayten Can1, Seldag Bekpinar, Figen Gurdol, Yıldız Tutuncu, Yesim Unlucerci, Nevin Dinccag.   

Abstract

We tested the relationship between plasma levels of dimethylarginines (ADMA and SDMA) and glycaemic control in 43 type 2 diabetic patients. Type 2 diabetics with poor glycaemic control (HbA1c>6.5) had significantly lower SDMA and higher ADMA concentrations than those with well-controlled glycaemia (HbA1c<6.5).
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21889812     DOI： 10.1016/j.diabres.2011.08.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  12 in total

1.  An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus.

Authors:  Asja Začiragić; Jasminko Huskić; Nedžad Mulabegović; Nesina Avdagić; Amina Valjevac; Sabaheta Hasić; Radivoj Jadrić
Journal:  Bosn J Basic Med Sci       Date:  2014-02       Impact factor: 3.363

2.  ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes.

Authors:  Radosław Wieczór; Anna M Wieczór; Arleta Kulwas; Danuta Rość
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

3.  Plasma ADMA associates with all-cause mortality in renal transplant recipients.

Authors:  Anne-Roos S Frenay; Else van den Berg; Martin H de Borst; Bibiana Beckmann; Dimitrios Tsikas; Martin Feelisch; Gerjan Navis; Stephan J L Bakker; Harry van Goor
Journal:  Amino Acids       Date:  2015-06-16       Impact factor: 3.520

4.  The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.

Authors:  Alpay Aribas; Mehmet Kayrak; Mehmet Tekinalp; Hakan Akilli; Hayrudin Alibasic; Serkan Yildirim; Mehmet Gunduz; Alpaslan Taner; Ali Unlu
Journal:  Korean J Intern Med       Date:  2015-04-29       Impact factor: 2.884

5.  Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.

Authors:  Chiao-Po Hsu; Pai-Feng Hsu; Ming-Yi Chung; Shing-Jong Lin; Tse-Min Lu
Journal:  Cardiovasc Diabetol       Date:  2014-12-03       Impact factor: 9.951

6.  Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome.

Authors:  Rob M Moonen; Maurice J Huizing; Giacomo Cavallaro; Gema E González-Luis; Pilar Bas-Suárez; Jaap A Bakker; Eduardo Villamor
Journal:  Int J Mol Sci       Date:  2014-12-23       Impact factor: 5.923

7.  Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.

Authors:  R Langhorn; I N Kieler; J Koch; L B Christiansen; L R Jessen
Journal:  J Vet Intern Med       Date:  2017-12-12       Impact factor: 3.333

8.  Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2017-03-14

9.  Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites.

Authors:  Annieke C G van Baar; Andrei Prodan; Camilla D Wahlgren; Steen S Poulsen; Filip K Knop; Albert K Groen; Jacques J Bergman; Max Nieuwdorp; Evgeni Levin
Journal:  Endocr Connect       Date:  2018-04-18       Impact factor: 3.335

10.  Transsulfuration pathway thiols and methylated arginines: the Hunter Community Study.

Authors:  Arduino A Mangoni; Angelo Zinellu; Ciriaco Carru; John R Attia; Mark McEvoy
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.